Mayinglong Pharmaceutical Group Co Ltd (600993) — Tangible Net Worth Ratio
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Tangible Net Worth Ratio of 95.1% as of March 2026. This metric is calculated by deducting intangible assets (CN¥232.85 Million) from net assets (CN¥4.73 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 600993 current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Mayinglong Pharmaceutical Group Co Ltd Tangible Net Worth Ratio (2001–2025)
This chart shows how Mayinglong Pharmaceutical Group Co Ltd's Tangible Net Worth Ratio has changed across 25 annual periods from 2001 to 2025. As of March 2026, the ratio stands at 95.1%, reflecting net assets of CN¥4.73 Billion with intangible assets of CN¥232.85 Million CNY. See 600993 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Mayinglong Pharmaceutical Group Co Ltd (2001–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Mayinglong Pharmaceutical Group Co Ltd from 2001 to 2025, covering 25 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Mayinglong Pharmaceutical Group Co Ltd.
| Year | Tangible NW Ratio | Net Assets (CNY) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.9% | CN¥4.51 Billion | CN¥229.40 Million | CN¥5.44 Billion | ▼ -0.3 pp |
| 2024 | 95.2% | CN¥4.20 Billion | CN¥200.10 Million | CN¥5.18 Billion | ▼ -0.6 pp |
| 2023 | 95.8% | CN¥3.87 Billion | CN¥161.77 Million | CN¥4.83 Billion | ▼ -2.0 pp |
| 2022 | 97.8% | CN¥3.62 Billion | CN¥80.20 Million | CN¥5.06 Billion | ▼ -0.2 pp |
| 2021 | 98.0% | CN¥3.31 Billion | CN¥67.20 Million | CN¥4.13 Billion | ▲ +0.1 pp |
| 2020 | 97.9% | CN¥2.95 Billion | CN¥62.28 Million | CN¥3.87 Billion | ▼ -0.5 pp |
| 2019 | 98.4% | CN¥2.63 Billion | CN¥43.44 Million | CN¥3.29 Billion | ▼ 0.0 pp |
| 2018 | 98.4% | CN¥2.35 Billion | CN¥37.61 Million | CN¥2.93 Billion | ▼ -0.1 pp |
| 2017 | 98.5% | CN¥2.27 Billion | CN¥33.05 Million | CN¥2.75 Billion | ▲ +0.1 pp |
| 2016 | 98.4% | CN¥2.02 Billion | CN¥32.09 Million | CN¥2.50 Billion | ▼ -0.2 pp |
| 2015 | 98.6% | CN¥1.89 Billion | CN¥26.81 Million | CN¥2.41 Billion | ▼ 0.0 pp |
| 2014 | 98.6% | CN¥1.70 Billion | CN¥23.44 Million | CN¥2.19 Billion | ▲ +0.0 pp |
| 2013 | 98.6% | CN¥1.57 Billion | CN¥22.28 Million | CN¥2.03 Billion | ▲ +0.2 pp |
| 2012 | 98.4% | CN¥1.43 Billion | CN¥22.81 Million | CN¥1.84 Billion | ▲ +1.2 pp |
| 2011 | 97.2% | CN¥1.32 Billion | CN¥36.84 Million | CN¥1.66 Billion | ▲ +0.5 pp |
| 2010 | 96.7% | CN¥1.13 Billion | CN¥37.08 Million | CN¥1.45 Billion | ▼ -0.1 pp |
| 2009 | 96.8% | CN¥1.05 Billion | CN¥34.02 Million | CN¥1.44 Billion | ▲ +0.6 pp |
| 2008 | 96.1% | CN¥871.43 Million | CN¥33.70 Million | CN¥1.16 Billion | ▲ +0.2 pp |
| 2007 | 96.0% | CN¥853.12 Million | CN¥34.34 Million | CN¥1.09 Billion | ▼ -3.0 pp |
| 2006 | 98.9% | CN¥855.21 Million | CN¥9.07 Million | CN¥1.11 Billion | ▼ -0.4 pp |
| 2005 | 99.3% | CN¥596.55 Million | CN¥4.14 Million | CN¥772.00 Million | ▼ -0.2 pp |
| 2004 | 99.5% | CN¥552.20 Million | CN¥2.76 Million | CN¥682.94 Million | ▲ +1.0 pp |
| 2003 | 98.5% | CN¥231.35 Million | CN¥3.42 Million | CN¥367.95 Million | ▲ +0.3 pp |
| 2002 | 98.2% | CN¥204.54 Million | CN¥3.65 Million | CN¥363.13 Million | ▼ -0.1 pp |
| 2001 | 98.3% | CN¥172.01 Million | CN¥2.90 Million | CN¥320.89 Million | — |